Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)
NCT07010380 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2025-06-18
Summary
This study tests PTFinder, a dual-camera system that makes parathyroid glands glow on screen by capturing their natural near-infrared autofluorescence. After a thyroid or parathyroid operation, the removed tissue is scanned with PTFinder and then checked again under normal white light. We will measure how fast (seconds) and how accurately the device finds real glands, confirmed by frozen pathology or a rapid PTH strip. About 180 adult patients at three Chinese hospitals will join. The imaging adds only a few minutes and does not change any part of the surgery. We will also record blood calcium and PTH at 1 h, 24 h, and 7 d after surgery to see whether better gland recovery lowers low-calcium risk.Collected images will also be used to train and test a deep-learning model for fully automated parathyroid recognition; model performance metrics constitute secondary outcomes.
Conditions
- Thyroid Neoplasms
- Hyperparathyroidism
- Parathyroid Gland
Interventions
- DEVICE
-
PTFinder Dual-Channel NIR Autofluorescence Imaging System
Ex vivo, non-contact imaging of resected thyroid/parathyroid specimens; captures near-infrared autofluorescence and overlays it on white-light video to highlight parathyroid glands (2-5 min per specimen).
- OTHER
-
Offline Machine-Learning Algorithm (PTFinder-AI Beta)
training/validation on de-identified NIR/RGB frames.
Sponsors & Collaborators
-
Bo Wang,MD
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2027-12-31
- Completion
- 2029-12-31
- FDA Device
- Yes
Countries
- China
Study Locations
More Related Trials
-
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
NCT05828238 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
FCH PET/MRI Parathyroid Localization
NCT03324893 ·Status: COMPLETED ·Phase: NA
-
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768 ·Status: RECRUITING
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
NCT06359795 ·Status: RECRUITING ·Phase: NA
-
Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
NCT04040946 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
NCT07132645 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fluorescence Imaging in Head and Neck Cancer
NCT03297957 ·Status: TERMINATED ·Phase: NA
-
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
NCT06543108 ·Status: RECRUITING
-
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110 ·Status: RECRUITING ·Phase: NA
-
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
NCT05490264 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT06277180 ·Status: RECRUITING ·Phase: NA
-
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
NCT01501630 ·Status: COMPLETED
-
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
NCT07138716 ·Status: RECRUITING ·Phase: NA
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
NCT02817945 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer
NCT02103634 ·Status: COMPLETED
-
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
NCT06455761 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
NCT03288597 ·Status: UNKNOWN
-
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
NCT06182644 ·Status: RECRUITING ·Phase: NA
-
Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
NCT00373711 ·Status: WITHDRAWN
-
Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
NCT06947096 ·Status: ENROLLING_BY_INVITATION
-
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
NCT07102056 ·Status: NOT_YET_RECRUITING
-
The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas
NCT04570033 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
NCT03830242 ·Status: UNKNOWN ·Phase: NA